Under the R2D2 initiative, Health Canada has committed to modernizing its regulatory system to provide more timely access to drugs and devices. Through various projects undertaken to-date, Health Canada has paved the way in many areas including: regulatory reliance through international work sharing, integration of real world evidence in regulatory decision-making, improving drug safety with implementation of Vanessa’s Law, and updating The Distinction guidance to reflect the current practices of advertising of medical products.
To support continuous learning, DIA brings you complimentary digital downloads to spur thought, reflection, collaboration, and action. In your Resource Kit, you'll find links to intriguing articles from the DIA Global Forum, exclusive podcast interviews, session recordings from DIA events, and more!
Shifting Biosimilar Access Policies to Promote Fiscal Sustainability in Canada
Canada's Shared Vision for Collaborative Healthcare Innovation
Podcast: Regulatory Modernization in Health and Biosciences
On-Demand Content Preview Webinar: Cybersecurity and Implications for Pharmacovigilance
On-Demand Content Preview Webinar: Key Factors for Success for Dossiers Relying on Third-Party Data (SRTD)